Skip to main
RYTM
RYTM logo

Rhythm Pharmaceuticals (RYTM) Market Capitalization Overview

Market Cap: $4.01B as of Jun 13, 2025

$4.01B
Past Month+$173.06M (4.52%)
As of Jun 13, 2025, Rhythm Pharmaceuticals (RYTM) has a market capitalization of $4.01B. Over the past 30 days, its market cap has decreased by -0.09%, while in the last 12 months, it has increased by 16.32%.

Market capitalization represents the total value of Rhythm Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Rhythm Pharmaceuticals (RYTM) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Rhythm Pharmaceuticals (RYTM) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Rhythm Pharmaceuticals (RYTM) Market Cap History

DateMarket CapChange
Jun 2, 2025$4.06B-0.09%
May 1, 2025$4.06B+28.24%
Apr 1, 2025$3.17B-3.31%
Mar 3, 2025$3.27B-10.46%
Feb 3, 2025$3.66B-1.10%
Jan 2, 2025$3.70B-1.27%

Rhythm Pharmaceuticals (RYTM) End of Year Market Cap History

DateMarket CapChange
2025$4.01B+16.32%
2024$3.45B+26.64%
2023$2.72B+65.56%
2022$1.65B+227.08%
2021$501.68M-61.83%
2020$1.32B

FAQs About Rhythm Pharmaceuticals (RYTM) Market Cap

As of Jun 13, 2025, the market capitalization of Rhythm Pharmaceuticals (RYTM) is $4.01B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Rhythm Pharmaceuticals’s market capitalization has increased by 4.52%, changing from $3.83B to $4.01B as of Jun 13, 2025.

In the last 3 months, Rhythm Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Rhythm Pharmaceuticals’s market capitalization increased from $2.72B in January to $3.45B in December, reflecting a 26.64% change.

In the past five years, Rhythm Pharmaceuticals (RYTM) has had a compound annual growth rate (CAGR) of 21.22% in market capitalization. This means its market cap has grown at an average rate of 21.22% per year.

Rhythm Pharmaceuticals (RYTM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.